The influence of tumor stage on the prognostic value of Ki-67 index and mitotic count in small intestinal neuroendocrine tumors

Yu Sun, Christine Lohse, Thomas Christopher Smyrk, Timothy James Hobday, Trynda Kroneman, Lizhi Zhang

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Tumor cell proliferation rate determined by either Ki- 67 index or mitotic count (MC) has shown to be a prognostic factor for gastrointestinal neuroendocrine tumors in general, and after its incorporation in the 2010 World Health Organization tumor grading system, it has become essentially mandatory in pathology reports for all gastrointestinal neuroendocrine tumors, regardless of tumor location. Nevertheless, clinical significance for the Ki-67 index or MC has not been well demonstrated in small intestinal neuroendocrine tumor (SINET), especially those without distant metastasis, the majority of which have very low proliferation rates. We assessed the clinical behavior of 130 SINETs in relation to stage, Ki-67 index, MC, and other pathologic features. Most SINETs (86%) were grade 1 and 14% were grade 2. There were no grade 3 tumors or poorly differentiated neuroendocrine carcinomas. On multivariate analysis, age, Ki-67 index > 5%, MC > 10/50 high-power field, stage IV, and liver metastases were associated with increased risk of death in all patients. When both stage and grade were considered, Ki-67 index > 5% was associated with a nearly 4-fold increased risk of death in stage IV cases (n= 60). In contrast, Ki-67 index did not show prognostic value for patients with stages I to III disease (n= 70), although MC > 1/50 high-power field was significantly associated with death on multivariable analysis. Our study confirms that liver metastasis and increased tumor cell proliferation rate are independent prognostic factors for SINETs, but shows that most SINETs have a very low proliferation rate, which limits its value for predicting tumor behavior. By combining staging and grading information, we demonstrate different roles and cutoff values of Ki-67 index and MC in SINET with different stages.

Original languageEnglish (US)
Pages (from-to)247-255
Number of pages9
JournalAmerican Journal of Surgical Pathology
Volume42
Issue number2
DOIs
StatePublished - Jan 1 2018

Fingerprint

Mitotic Index
Neuroendocrine Tumors
Neoplasms
Neoplasm Metastasis
Cell Proliferation
Neuroendocrine Carcinoma
Neoplasm Grading
Liver
Multivariate Analysis
Pathology

Keywords

  • Ki-67
  • Mitotic count
  • Neuroendocrine tumor
  • Prognosis
  • Small intestine

ASJC Scopus subject areas

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

Cite this

The influence of tumor stage on the prognostic value of Ki-67 index and mitotic count in small intestinal neuroendocrine tumors. / Sun, Yu; Lohse, Christine; Smyrk, Thomas Christopher; Hobday, Timothy James; Kroneman, Trynda; Zhang, Lizhi.

In: American Journal of Surgical Pathology, Vol. 42, No. 2, 01.01.2018, p. 247-255.

Research output: Contribution to journalArticle

@article{2e3517f9382d43aa80c02c0dca80d32d,
title = "The influence of tumor stage on the prognostic value of Ki-67 index and mitotic count in small intestinal neuroendocrine tumors",
abstract = "Tumor cell proliferation rate determined by either Ki- 67 index or mitotic count (MC) has shown to be a prognostic factor for gastrointestinal neuroendocrine tumors in general, and after its incorporation in the 2010 World Health Organization tumor grading system, it has become essentially mandatory in pathology reports for all gastrointestinal neuroendocrine tumors, regardless of tumor location. Nevertheless, clinical significance for the Ki-67 index or MC has not been well demonstrated in small intestinal neuroendocrine tumor (SINET), especially those without distant metastasis, the majority of which have very low proliferation rates. We assessed the clinical behavior of 130 SINETs in relation to stage, Ki-67 index, MC, and other pathologic features. Most SINETs (86{\%}) were grade 1 and 14{\%} were grade 2. There were no grade 3 tumors or poorly differentiated neuroendocrine carcinomas. On multivariate analysis, age, Ki-67 index > 5{\%}, MC > 10/50 high-power field, stage IV, and liver metastases were associated with increased risk of death in all patients. When both stage and grade were considered, Ki-67 index > 5{\%} was associated with a nearly 4-fold increased risk of death in stage IV cases (n= 60). In contrast, Ki-67 index did not show prognostic value for patients with stages I to III disease (n= 70), although MC > 1/50 high-power field was significantly associated with death on multivariable analysis. Our study confirms that liver metastasis and increased tumor cell proliferation rate are independent prognostic factors for SINETs, but shows that most SINETs have a very low proliferation rate, which limits its value for predicting tumor behavior. By combining staging and grading information, we demonstrate different roles and cutoff values of Ki-67 index and MC in SINET with different stages.",
keywords = "Ki-67, Mitotic count, Neuroendocrine tumor, Prognosis, Small intestine",
author = "Yu Sun and Christine Lohse and Smyrk, {Thomas Christopher} and Hobday, {Timothy James} and Trynda Kroneman and Lizhi Zhang",
year = "2018",
month = "1",
day = "1",
doi = "10.1097/PAS.0000000000000968",
language = "English (US)",
volume = "42",
pages = "247--255",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The influence of tumor stage on the prognostic value of Ki-67 index and mitotic count in small intestinal neuroendocrine tumors

AU - Sun, Yu

AU - Lohse, Christine

AU - Smyrk, Thomas Christopher

AU - Hobday, Timothy James

AU - Kroneman, Trynda

AU - Zhang, Lizhi

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Tumor cell proliferation rate determined by either Ki- 67 index or mitotic count (MC) has shown to be a prognostic factor for gastrointestinal neuroendocrine tumors in general, and after its incorporation in the 2010 World Health Organization tumor grading system, it has become essentially mandatory in pathology reports for all gastrointestinal neuroendocrine tumors, regardless of tumor location. Nevertheless, clinical significance for the Ki-67 index or MC has not been well demonstrated in small intestinal neuroendocrine tumor (SINET), especially those without distant metastasis, the majority of which have very low proliferation rates. We assessed the clinical behavior of 130 SINETs in relation to stage, Ki-67 index, MC, and other pathologic features. Most SINETs (86%) were grade 1 and 14% were grade 2. There were no grade 3 tumors or poorly differentiated neuroendocrine carcinomas. On multivariate analysis, age, Ki-67 index > 5%, MC > 10/50 high-power field, stage IV, and liver metastases were associated with increased risk of death in all patients. When both stage and grade were considered, Ki-67 index > 5% was associated with a nearly 4-fold increased risk of death in stage IV cases (n= 60). In contrast, Ki-67 index did not show prognostic value for patients with stages I to III disease (n= 70), although MC > 1/50 high-power field was significantly associated with death on multivariable analysis. Our study confirms that liver metastasis and increased tumor cell proliferation rate are independent prognostic factors for SINETs, but shows that most SINETs have a very low proliferation rate, which limits its value for predicting tumor behavior. By combining staging and grading information, we demonstrate different roles and cutoff values of Ki-67 index and MC in SINET with different stages.

AB - Tumor cell proliferation rate determined by either Ki- 67 index or mitotic count (MC) has shown to be a prognostic factor for gastrointestinal neuroendocrine tumors in general, and after its incorporation in the 2010 World Health Organization tumor grading system, it has become essentially mandatory in pathology reports for all gastrointestinal neuroendocrine tumors, regardless of tumor location. Nevertheless, clinical significance for the Ki-67 index or MC has not been well demonstrated in small intestinal neuroendocrine tumor (SINET), especially those without distant metastasis, the majority of which have very low proliferation rates. We assessed the clinical behavior of 130 SINETs in relation to stage, Ki-67 index, MC, and other pathologic features. Most SINETs (86%) were grade 1 and 14% were grade 2. There were no grade 3 tumors or poorly differentiated neuroendocrine carcinomas. On multivariate analysis, age, Ki-67 index > 5%, MC > 10/50 high-power field, stage IV, and liver metastases were associated with increased risk of death in all patients. When both stage and grade were considered, Ki-67 index > 5% was associated with a nearly 4-fold increased risk of death in stage IV cases (n= 60). In contrast, Ki-67 index did not show prognostic value for patients with stages I to III disease (n= 70), although MC > 1/50 high-power field was significantly associated with death on multivariable analysis. Our study confirms that liver metastasis and increased tumor cell proliferation rate are independent prognostic factors for SINETs, but shows that most SINETs have a very low proliferation rate, which limits its value for predicting tumor behavior. By combining staging and grading information, we demonstrate different roles and cutoff values of Ki-67 index and MC in SINET with different stages.

KW - Ki-67

KW - Mitotic count

KW - Neuroendocrine tumor

KW - Prognosis

KW - Small intestine

UR - http://www.scopus.com/inward/record.url?scp=85043683840&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043683840&partnerID=8YFLogxK

U2 - 10.1097/PAS.0000000000000968

DO - 10.1097/PAS.0000000000000968

M3 - Article

C2 - 29016403

AN - SCOPUS:85043683840

VL - 42

SP - 247

EP - 255

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 2

ER -